Market Leadership Covance is recognized as a leading global contract research organization with a strong reputation, including awards such as the CRO Company of the Year in 2020 and repeated accolades in quality assessments, positioning it as a trusted partner for innovative drug development projects.

Expanding Facilities Recent investments in expanding and renovating preclinical oncology facilities in Ann Arbor highlight Covance's focus on strengthening capabilities in oncology research, presenting opportunities for partners offering cutting-edge laboratory technologies and equipment.

Strategic Collaborations Partnerships with organizations like Tempus indicate Covance’s willingness to collaborate for accelerated timelines in clinical development, creating avenues for tech providers and data analytics companies to support its integrated research solutions.

Technology Integration Covance employs a diverse tech stack, including Salesforce and Python, signifying a commitment to digital transformation; tech vendors offering innovative solutions in automation, data management, and lifecycle management can find sales opportunities within its operational ecosystem.

Growth & Recruitment With a workforce nearing 10,000 employees and a broad client base that helps develop most top-prescription drugs, Covance offers expansion opportunities for service providers in areas like staffing, specialized clinical services, and regulatory consulting to support its ongoing growth.